From: Towards early detection of adverse drug reactions: combining pre-clinical drug structures and post-market safety reports
Reports with ADR
Reports without ADR
Total
Reports with drug
a
b
a+b
Reports without drug
c
d
c+d
a+c
b+d
a + b + c + d